Nalaganje...

Targeting TFPI for hemophilia treatment

Hemophilia is a severe bleeding disorder treated by infusion of the missing blood coagulation protein, factor VIII or factor IX. The discovery and characterization of the anticoagulant protein tissue factor pathway inhibitor (TFPI) led to the realization that inhibition of TFPI activity could restor...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Thromb Res
Main Authors: Peterson, Julie A., Maroney, Susan A., Mast, Alan E.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950664/
https://ncbi.nlm.nih.gov/pubmed/27207418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0049-3848(16)30359-0
Oznake: Označite
Brez oznak, prvi označite!